Flexion Therapeutics (FLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FLXN | TBPH | ZVRA | ||
| Company | Flexion Therapeutics | Theravance Bio Ord | Zevra Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.14 | 9.82 | 8.56 | ||
| High | 9.23 | 9.89 | 8.65 | ||
| Low | 9.12 | 9.72 | 8.42 | ||
| Last | 9.12 | 9.85 | 8.59 | ||
| Change | -0.02 | +0.06 | +0.01 | ||
| % Change | -0.22% | +0.61% | +0.12% | ||
| Volume | 18,723,200 | 37,900 | 138,500 | ||
| 20-Day Average Volume | 2,000,190 | 197,570 | 516,420 | ||
| Previous Close | 9.14 | 9.79 | 8.58 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.24 | 9.74 | 8.88 | ||
| 20-Day Raw Stochastic | 6.06% | 63.96% | 26.58% | ||
| 20-Day Relative Strength | 62.41% | 56.87% | 48.80% | ||
| Weighted Alpha | -43.65 | -1.60 | +27.11 | ||
| Today's Opinion | 56% Buy | 88% Buy | 56% Buy | ||
| Previous Opinion | 56% Buy | 88% Buy | 56% Buy | ||
| Last Month's Opinion | 24% Buy | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.76% since 11/11/21 | -1.10% since 12/17/24 | +1.30% since 12/17/24 | ||
| Low | 9.12 on 11/18/21 | 9.53 on 12/23/24 | 8.17 on 12/18/24 | ||
| High | 9.23 on 11/12/21 | 10.08 on 12/18/24 | 8.83 on 12/20/24 | ||
| 1-Month | |||||
| %Chg | -2.04% since 10/18/21 | +4.01% since 11/22/24 | -10.38% since 11/22/24 | ||
| Low | 9.10 on 11/10/21 | 9.14 on 12/02/24 | 8.17 on 12/18/24 | ||
| High | 9.43 on 10/22/21 | 10.25 on 12/09/24 | 9.76 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +92.00% since 08/18/21 | +22.82% since 09/24/24 | +3.87% since 09/24/24 | ||
| Low | 4.30 on 08/20/21 | 7.88 on 10/09/24 | 6.61 on 10/01/24 | ||
| High | 9.89 on 10/11/21 | 10.26 on 11/13/24 | 9.76 on 11/25/24 | ||
| 6-Month | |||||
| %Chg | +7.93% since 05/18/21 | +12.31% since 06/24/24 | +90.89% since 06/24/24 | ||
| Low | 4.30 on 08/20/21 | 7.44 on 08/09/24 | 4.20 on 07/05/24 | ||
| High | 9.89 on 10/11/21 | 10.42 on 07/26/24 | 9.76 on 11/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 458,927 | 481,413 | 457,966 | ||
| Shares Outstanding, K | 50,321 | 49,174 | 53,376 | ||
| Annual Sales | 85,550,000 | 57,420,000 | 27,460,000 | ||
| Annual Net Income | -113,710,000 | -55,190,000 | -46,050,000 | ||
| Last Quarter Sales | 28,180,000 | 16,870,000 | 3,700,000 | ||
| Last Quarter Net Income | -22,210,000 | -12,700,000 | -33,230,000 | ||
| 60-Month Beta | 1.53 | 0.23 | 1.97 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | -0.06 on 11/12/24 | -0.69 on 11/12/24 | ||
| Latest Earnings Date | 11/17/21 | 11/12/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||